Stephens Inc Regeneron Pharmaceuticals, Inc. Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stephens Inc holds 954 shares of REGN stock, worth $679,629. This represents 0.01% of its overall portfolio holdings.

Number of Shares

954

Previous 955 0.1%

Holding current value

$679,629

Previous $1 Million 0.1%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$1024.09 - $1201.76 $1,024 - $1,201	-1 Reduced 0.1%	954 $1 Million
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $37,094 - $44,989	42 Added 4.6%	955 $1 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $173,316 - $190,723	192 Added 26.63%	913 $878,000
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $65,115 - $74,062	84 Added 13.19%	721 $633,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $3,462 - $4,221	-5 Reduced 0.78%	637 $524,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $3,500 - $4,151	-5 Reduced 0.77%	642 $461,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $48,995 - $59,541	-72 Reduced 10.01%	647 $531,000
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $5,739 - $7,243	-10 Reduced 1.37%	719 $495,000
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $1,645 - $2,216	-3 Reduced 0.41%	729 $431,000
Q4 2021 Mar 07, 2022	SELL	$543.48 - $670.97 $2,717 - $3,354	-5 Reduced 0.68%	732 $462,000
Q3 2021 Oct 27, 2021	SELL	$574.03 - $680.96 $4,018 - $4,766	-7 Reduced 0.94%	737 $446,000
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $47,280 - $55,854	-100 Reduced 11.85%	744 $416,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $5.99 Million - $7.35 Million	-13,401 Reduced 94.08%	844 $399,000
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $467,777 - $594,604	978 Added 7.37%	14,245 $6.88 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $135,642 - $163,894	249 Added 1.91%	13,267 $7.43 Million
Q2 2020 Aug 24, 2020	SELL	$493.32 - $643.92 $71,531 - $93,368	-145 Reduced 1.1%	13,018 $8.12 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $561,420 - $825,698	1,670 Added 14.53%	13,163 $6.43 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $511,526 - $702,567	1,866 Added 19.38%	11,493 $4.32 Million
Q3 2019 Oct 18, 2019	BUY	$273.46 - $318.39 $134,542 - $156,647	492 Added 5.39%	9,627 $2.67 Million
Q2 2019 Aug 01, 2019	SELL	$299.6 - $414.82 $44,640 - $61,808	-149 Reduced 1.6%	9,135 $2.86 Million
Q1 2019 May 03, 2019	BUY	$372.08 - $439.57 $2,976 - $3,516	8 Added 0.09%	9,284 $3.81 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $83,619 - $100,356	249 Added 2.76%	9,276 $3.47 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $3.17 Million - $3.69 Million	9,027 New	9,027 $3.65 Million
Q3 2017 Nov 08, 2017	SELL	$431.38 - $504.0 $3.49 Million - $4.08 Million	-8,097 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	8,097	8,097 $3.98 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account